68Ga-NTA-476 Imaging in Prostate Cancer

NCT06520449 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

10

Enrollment

NETWORK

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: 68Ga-NTA-476

Sponsor

Melbourne Theranostic Innovation Centre

Collaborators

[object Object]